Development of an optimized hyaluronic acid-based lipidic nanoemulsion co-encapsulating two polyphenols for nose to brain delivery

Drug Delivery

Volumn 23, Issue 4, 2016, Pages 1444-1452

  Nasr, Maha ^a  

^a Ain Shams University   (Egypt)

Author keywords

Curcumin; intranasal; neurodegenerative; resveratrol; stability

Indexed keywords

ANTIOXIDANT; CURCUMIN; HYALURONIC ACID; RESVERATROL; EMULSION; LIPID; NANOPARTICLE; POLYPHENOL; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DEGENERATIVE DISEASE; DEGRADATION; DPPH RADICAL SCAVENGING ASSAY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG RELEASE; DRUG SAFETY; DRUG STABILITY; EMULSION; EX VIVO STUDY; IN VITRO STUDY; IN VIVO STUDY; MALE; MORPHOLOGY; NANOEMULSION; NANOENCAPSULATION; NONHUMAN; NOSE; NOSE MUCOSA; PARTICLE SIZE; PH; PRIORITY JOURNAL; RAT; STORAGE; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DRUG EFFECTS; GENETICS; INTRANASAL DRUG ADMINISTRATION; METABOLISM; SHEEP;

ADMINISTRATION, INTRANASAL; ANIMALS; BRAIN; CURCUMIN; EMULSIONS; HYALURONIC ACID; LIPIDS; NANOPARTICLES; NASAL MUCOSA; NEURODEGENERATIVE DISEASES; POLYPHENOLS; RATS; SHEEP; STILBENES;

EID: 84945231722     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2015.1092619     Document Type: Article

References (49)

1. H.M.Abdel-Bar, A.Y.Abdel-Reheem, G.A.Awad, N.D.Mortada. (2013). Evaluation of brain targeting and mucosal integrity of nasally administrated nanostructured carriers of a CNS active drug, clonazepam. J Pharm Pharm Sci 16:456–69
2. N.Aftab, A.Vieira. (2010). Antioxidant activities of curcumin and combinations of this curcuminoid with other phytochemicals. Phytother Res 24:500–2
3. R.Agrawal, B.Mishra, E.Tyagi,. (2010). Effect of curcumin on brain insulin receptors and memory functions in STZ(ICV) induced dementia model of rat. Pharmacol Res 61:247–52
4. A.Amri, J.C.Chaumeil, S.Sfar, C.Charrueau. (2012). Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release 158:182–93
5. A.Amri, S.Le Clanche, P.Therond,. (2014). Resveratrol self-emulsifying system increases the uptake by endothelial cells and improves protection against oxidative stress-mediated death. Eur J Pharm Biopharm 86:418–26
6. S.Basavaraj, G.V.Betageri. (2014). Improved oral delivery of resveratrol using proliposomal formulation: investigation of various factors contributing to prolonged absorption of unmetabolized resveratrol. Expert Opin Drug Deliv 11:493–503
7. H.Bshara, R.Osman, S.Mansour, H.El-Shamy Ael. (2014). Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats. Carbohydr Polym 99:297–305
8. C.Caddeo, M.Manconi, A.M.Fadda,. (2013). Nanocarriers for antioxidant resveratrol: formulation approach, vesicle self-assembly and stability evaluation. Colloids Surf B Bionterfaces 111:327–32
9. C.Caddeo, K.Teskac, C.Sinico, J.Kristl. (2008). Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells. Int J Pharm 363:183–91
10. X.Chen, F.Zhi, X.Jia,. (2013). Enhanced brain targeting of curcumin by intranasal administration of a thermosensitive poloxamer hydrogel. J Pharm Pharmacol 65:807–16
11. M.Coimbra, B.Isacchi, L.van Bloois,. (2011). Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes. Int J Pharm 416:433–42
12. K.Coradini, F.O.Lima, C.M.Oliveira,. (2014). Co-encapsulation of resveratrol and curcumin in lipid-core nanocapsules improves their in vitro antioxidant effects. Eur J Pharm Biopharm 88:178–85
13. G.Davidov-Pardo, D.J.McClements. (2015). Nutraceutical delivery systems: resveratrol encapsulation in grape seed oil nanoemulsions formed by spontaneous emulsification. Food Chem 167:205–12
14. F.Donsi, M.Sessa, H.Mediouni,. (2011). Encapsulation of bioactive compounds in nanoemulsion based delivery systems. Procedia Food Sci 1:1666–71
15. R.L.Frozza, C.Salbego, A.Bernardi,. (2011). Incorporation of resveratrol into lipid-core nanocapsules improves its cerebral bioavailability and reduces the Aβ-induced toxicity. Alzheimers Dement 7:S114
16. Y.M.Gabal, A.O.Kamel, O.A.Sammour, A.H.Elshafeey. (2014). Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route. Int J Pharm 473:442–57
17. M.Gregori, M.Masserini, S.Mancini. (2015). Nanomedicine for the treatment of Alzheimer's disease. Nanomedicine (Lond) 10:1203–18
18. M.L.Holland, J.A.Panetta, J.M.Hoskins,. (2006). The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells. Biochem Pharmacol 71:1146–54
19. S.Horvát, A.Fehér, H.Wolburg,. (2009). Sodium hylauronate as a mucoadhesive component in nasal formulation enhances delivery of molecules to brain tissue. Eur J Pharm Biopharm 72:252–9
20. H.K.Ibrahim, I.S.El-Leithy, A.A.Makky. (2010). Mucoahesive nanoparticles as carrier systems for prolonged ocular delivery of gatifloxacin/prednisolone biotherapy. Mol Pharm 7:576–85
21. A.Kumar, P.S.Naidu, N.Seghal, S.S.Padi. (2007). Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology 79:17–26
22. M.Kumar, A.Misra, A.K.Babbar,. (2008). Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm 358:285–91
23. H.Kusuhara, H.Furuie, A.Inano,. (2012). Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP. Br J Pharmacol 166:1793–803
24. W.Loscher, H.Potschka. (2005). Blood-brain barrier active efflux transporters: ATP-binding cassette gene family. NeuroRx 2:86–98
25. C.Lovelyn, A.Attama. (2011). Current state of nanoemulsions in drug delivery. J Biomater Nanobiotechnol 2:626–39
26. C.Lucas-Abellán, I.Fortea, J.M.López-Nicolás, E.Nunez-Delicado. (2007). Cyclodextrins as resveratrol carrier system. Food Chem 104:39–44
27. T.Ma, M.S.Tan, J.T.Yu, L.Tan. (2014). Resveratrol as a therapeutic agent for Alzheimer's disease. Biomed Res Int 2014:350516
28. H.S.Mahajan, S.B.Dinger. (2011). Design and in vitro evaluation of nanoemulsion for nasal delivery of artemether. IJNDD 3:272–7
29. A.Monroy, G.J.Lithgow, S.Alavez. (2013). Curcumin and neurodegenerative diseases. Biofactors 39:122–32
30. C.Moorthi, C.Senthil Kumar, S.Mohan,. (2013). Application of validated RP-HPLC-PDA method for the simultaneous estimation of curcumin and piperine in Eudragit E 100 nanoparticles. J Pharm Res 7:224–9
31. T.Nabekura. (2010). Overcoming multidrug resistance in human cancer cells by natural compounds. Toxins (Basel) 2:1207–24
32. M.Nasr, G.A.Awad, S.Mansour,. (2011). Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. Eur J Pharm Biopharm 79:601–11
33. M.Nasr, S.Mansour, N.D.Mortada, A.A.El Shamy. (2008a). Lipospheres as carriers for topical delivery of aceclofenac: preparation, characterization and in vivo evaluation. AAPS Pharm Sci Tech 9:154–62
34. M.Nasr, S.Mansour, N.D.Mortada, A.A.Elshamy. (2008b). Vesicular aceclofenac systems: a comparative study between liposomes and niosomes. J Microencapsul 25:499–512
35. M.Nasr, S.Nawaz, A.Elhissi. (2012). Amphotericin B lipid nanoemulsion aerosols for targeting peripheral respiratory airways via nebulization. Int J Pharm 436:611–16
36. M.Nasr, I.Taha, R.M.Hathout. (2013). Suitability of liposomal carriers for systemic delivery of risedronate using the pulmonary route. Drug Deliv 20:311–18
37. H.Rachmawati, D.K.Budiputra, R.Mauludin. (2015). Curcumin nanoemulsion for transdermal application: formulation and evaluation. Drug Dev Ind Pharm 41:560–6
38. J.K.Sahni, S.Doqqui, J.Ali,. (2011). Neurotherapeutic applications of nanoparticles in Alzheimer's disease. J Control Release 152:208–31
39. A.Scheepens, K.Tan, J.W.Paxton. (2010). Improving the oral bioavailability of beneficial polyphenols through designed synergies. Genes Nutr 5:75–87
40. M.Sessa, M.L.Balestrieri, G.Ferrari,. (2014). Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems. Food Chem 147:42–50
41. M.Sessa, R.Tsao, R.Liu,. (2011). Evaluation of the stability and antioxidant activity of nanoencapsulated resveratrol during in vitro digestion. J Agric Food Chem 59:12352–60
42. M.Sharma, Y.K.Gupta. (2002). Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci 71:2489–98
43. H.Shen, S.Shi, Z.Zhang,. (2015). Coating solid lipid nanoparticles with hyaluronic acid enhances antitumor activity against melanoma stem-like cells. Theranostics 5:755–71
44. S.Sood, K.Jain, K.Gowthamarajan. (2013). Intranasal delivery of curcumin-/INS; donepezil nanoemulsion for brain targeting in Alzheimer's disease. J Neurol Sci 333:e316–17
45. S.Sood, K.Jain, K.Gowthamarajan. (2014). Optimization of curcumin nanoemulsion for intranasal delivery using design of experiment and its toxicity assessment. Colloids Surf B Biointerfaces 113:330–7
46. A.Y.Sun, Q.Wang, A.Simonyi, G.Y.Sun. (2010). Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol 41:375–83
47. L.Tavano, R.Muzzalupo, N.Picci, B.de Cindio. (2014). Co-encapsulation of lipophilic antioxidants into niosomal carriers: percutaneous permeation studies for cosmeceutical applications. Colloids Surf B Biointerfaces 114:144–9
48. K.Vanaja, M.A.Wahl, L.Bukarica, H.Heinle. (2013). Liposomes as carriers of the lipid soluble antioxidant resveratrol: evaluation of amelioration of oxidative stress by additional antioxidant vitamin. Life Sci 93:917–23
49. F.Yang, G.P.Lim, A.N.Begum,. (2005). Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques and reduces amyloid in vivo. J Biol Chem 280:5892–901